[Role of prebiotics and probiotics in therapeutic management of cryptogenetic inflammatory bowel disease].
Marteau
P
P
Service d'Hépato-Gastroentérologie, Hôpital Européen Georges Pompidou, 20 rue Leblanc, 75908 Paris. philippe.marteau@egp.ap-hop-paris.fr
Seksik
P
P
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy / Q000628:therapy*; D003424:Crohn Disease / Q000188:drug therapy / Q000628:therapy*; D004311:Double-Blind Method; D004926:Escherichia coli; D005612:Freeze Drying; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D019804:Mesalamine / Q000008:administration & dosage / Q000627:therapeutic use; D010919:Placebos; D019936:Probiotics; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012294:Rifamycins / Q000008:administration & dosage / Q000627:therapeutic use; D000078262:Rifaximin; D012440:Saccharomyces; D013997:Time Factors
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D005765:Gastrointestinal Agents; D010919:Placebos; D012294:Rifamycins; D019804:Mesalamine; D002939:Ciprofloxacin; D000078262:Rifaximin
Place des prébiotiques et probiotiques dans la prise en charge thérapeutique des maladies inflammatoires cryptogénétiques de l'intestin.